Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Fabbri

Showing results (11-20 of 218) with videos related to

Pageof 22
Sort By:
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 9, 2017
Role of 108 schizophrenia-associated loci in modulating psychopathological dimensions in schizophrenia and bipolar disorderChiara Fabbri, Alessandro Serretti
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|January 21, 2020
Genetics of Treatment Outcomes in Major Depressive Disorder: Present and FutureChiara Fabbri, Alessandro Serretti
Clinical Pharmacology and Therapeutics|October 5, 2019
Is Pharmacogenetics Useful in Antidepressant Treatment?Chiara Fabbri, Alessandro Serretti
The Lancet. Psychiatry|June 11, 2018
22q11.2 rearrangements: clinical and research implications of population-based risk of neuropsychiatric and developmental disordersChiara Fabbri, Alessandro Serretti
Neuroscience Letters|June 16, 2018
Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studiesChiara Fabbri, Alessandro Serretti
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|October 30, 2020
How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic ApproachChiara Fabbri, Alessandro Serretti
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 20, 2018
Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trialsChiara Fabbri, Joseph Zohar, Alessandro Serretti
Advances in Pharmacology (San Diego, Calif.)|May 27, 2018
Pharmacogenetics in PsychiatryFilippo Corponi, Chiara Fabbri, Alessandro Serretti
Journal of Psychiatric Research|May 5, 2015
Predictors of switch from depression to mania in bipolar disorderTomihisa Niitsu, Chiara Fabbri, Alessandro Serretti
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 6, 2011
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacyStefano Porcelli, Chiara Fabbri, Alessandro Serretti
Pageof 22

Showing results (11-20 of 218) with videos related to

Sort By:
Pageof 22
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 9, 2017
Role of 108 schizophrenia-associated loci in modulating psychopathological dimensions in schizophrenia and bipolar disorderChiara Fabbri, Alessandro Serretti
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|January 21, 2020
Genetics of Treatment Outcomes in Major Depressive Disorder: Present and FutureChiara Fabbri, Alessandro Serretti
Clinical Pharmacology and Therapeutics|October 5, 2019
Is Pharmacogenetics Useful in Antidepressant Treatment?Chiara Fabbri, Alessandro Serretti
The Lancet. Psychiatry|June 11, 2018
22q11.2 rearrangements: clinical and research implications of population-based risk of neuropsychiatric and developmental disordersChiara Fabbri, Alessandro Serretti
Neuroscience Letters|June 16, 2018
Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studiesChiara Fabbri, Alessandro Serretti
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|October 30, 2020
How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic ApproachChiara Fabbri, Alessandro Serretti
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 20, 2018
Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trialsChiara Fabbri, Joseph Zohar, Alessandro Serretti
Advances in Pharmacology (San Diego, Calif.)|May 27, 2018
Pharmacogenetics in PsychiatryFilippo Corponi, Chiara Fabbri, Alessandro Serretti
Journal of Psychiatric Research|May 5, 2015
Predictors of switch from depression to mania in bipolar disorderTomihisa Niitsu, Chiara Fabbri, Alessandro Serretti
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 6, 2011
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacyStefano Porcelli, Chiara Fabbri, Alessandro Serretti
Pageof 22